XClose

UCL Consultants

Home
Menu

UCLC news

Drug lowers deadly Huntington’s disease protein

The first drug targeting the cause of Huntington’s disease was safe and well-tolerated in its first human trial led by UCL scientists. It successfully lowered the level of the harmful huntington protein in the nervous system.